Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinitrobenzoic acid and 3,5-diamino benzoic acid. It also provides drug intermediates comprising 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4–amino pyridine, and 2–chloro–5–nitrobenzoic acid. In addition, the company exports its products. Arvee Laboratories (India) Ltd. was incorporated in 2012 and is based in Ahmedabad, India.
Metrics to compare | ARVE | Peers Peers - average of corresponding metrics from companies closely matching ARVE: TIRUMALCHM, FCL, 506687, PCCL, EIDPARRY | Sector Sector - Average of metrics from a broad group of related Basic Materials sector companies | Relationship RelationshipARVEPeersSector |
|---|---|---|---|---|
P/E Ratio | 128.1x | 31.9x | 0.2x | |
PEG Ratio | −14.46 | 0.45 | 0.00 | |
Price/Book | 5.6x | 2.8x | 1.6x | |
Price / LTM Sales | 5.0x | 1.2x | 1.4x | |
Upside (Analyst Target) | - | 16.3% | 24.1% | |
Fair Value Upside | Unlock | −6.4% | 0.9% | Unlock |